🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06955884
Recruiting Observational

Patient Experience of Transoral Versus Transnasal Awake Tracheal Intubation

NCT06955884 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2025-06-30
Last updated
2025-07-10

Condition(s) studied

Airway ManagementFiberoptic Guided IntubationPatient Experience

Study summary

Airway management problems are key drivers for anesthesia-related adverse events. Awake tracheal intubation using flexible bronchoscopy and preserved spontaneous breathing (ATI:FB) is a recommended technique to manage difficult tracheal intubation in anaesthesia, intensive care and emergency medicine. ATI:FB is regarded as the gold standard of tracheal intubation in many scenarios, however there is insufficient data on the patients experience while undergoing this form of airway management. ATI:FB can be facilitated using either a transnasal or transoral route. The study aims to compare patient-centred and operator-focused outcome parameters between these two different approaches with a focus on patient discomfort.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * patients scheduled for surgery requiring tracheal intubation * patients with an anticipated difficult airway requiring ATI:FB * consent by the patient * minimum 18 years of age Exclusion Criteria: * patients scheduled for surgery requiring tracheal intubation * patients not scheduled for ATI:FB * pregnant or breastfeeding patients * consent withheld or not possible to obtain by the patient

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Medical Center Hamburg-Eppendorf Hamburg Free and Hanseatic City of Hamburg Recruiting

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06955884 on ClinicalTrials.gov ↗ ← All trials in Germany